New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer (Cancer Therapy Advisor)

Clinicians may need to be more proactive in preventing and treating cardiovascular disease (CVD) in patients with prostate cancer who are receiving androgen deprivation therapy (ADT), according to researchers at Vanderbilt University in Nashville, TN. They reported that collaboration among subspecialties in medicine may be critical to preventing CVD deaths, the most common non-cancer cause of death for men with prostate cancer. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news